Pharmacokinetics of chloroquine in Thais: plasma and red-cell concentrations following an intravenous infusion to healthy subjects and patients with Plasmodium vivax malaria.-Reference-Cited by-同舟云学术

Pharmacokinetics of chloroquine in Thais: plasma and red-cell concentrations following an intravenous infusion to healthy subjects and patients with Plasmodium vivax malaria.

Published:1988-04 Issue:4 Volume:25 Page:477-485
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Edwards G,Looareesuwan S,Davies AJ,Wattanagoon Y,Phillips RE,Warrell DA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1988.tb03332.x/fullpdf

Reference17 articles.

1. Kinetics of the uptake and elimination of chloroquine in children with malaria;Adelusi;Br. J. clin. Pharmac.,1982

2. Determination of chloroquine and its desethyl metabolite in plasma, red blood cells and urine by liquid chromatography;Alvan;J. Chromatogr.,1982

3. Statistical estimations in pharmacokinetics;Boxenbaum;J. Pharmacokin Biopharm.,1974

4. Plasma concentrations and toxicity of chloroquine after slow intravenous infusion in patients with falciparum malaria;Edwards;Ann. Trop. Med. Parasitol.,1987

5. Pharmacokinetics

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of chloroquine in patients with malaria by P. vivax from the Western Brazilian Amazon basin;Biomedicine & Pharmacotherapy;2022-05

2. Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID‐19 Infection;Clinical Pharmacology & Therapeutics;2020-09

3. Population Pharmacokinetics and Pharmacodynamics of Chloroquine in a Plasmodium vivax Volunteer Infection Study;Clinical Pharmacology & Therapeutics;2020-07-02

4. Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model;Acta Pharmaceutica Sinica B;2020-07

5. Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties;Clinical Pharmacokinetics;2020-04-18